Does APIXABAN Cause Psychomotor hyperactivity? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Psychomotor hyperactivity have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
23
Reports of Psychomotor hyperactivity with APIXABAN
0.0%
of all APIXABAN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From APIXABAN?
Of the 23 reports, 19 (82.6%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which APIXABAN Alternatives Have Lower Psychomotor hyperactivity Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ